Revance Therapeutics, Inc. (RVNC) stock experienced sudden downfall – Reasons behind it!
Revance Therapeutics, Inc. (RVNC) has experienced a decline of 33.07% in the aftermarket because the company provided a Regulatory Update on DaxibotulinumtoxinA. However, the last